Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
MYC and Breast Cancer.
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer. 2019; 5:38.
View in:
PubMed
authors with profiles
Peter Hulick
Olufunmilayo Olopade